Single peptide Vial strength 20 mg
Vesugen (Lys-Glu-Asp)20 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Vesugen (Lys-Glu-Asp), explained simply
The KED bioregulatory tripeptide, discussed for experimental effects in endothelial cells.
Research area
Vascular bioregulation
How it works
Vesugen, also called KED, is a short bioregulatory peptide studied in endothelial-cell models.
Why it matters
The profile introduces vascular function and cellular-renewal signaling.
What has been observed
Experimental observations concern expression of proliferation markers in endothelial cells.
Effects and points to consider
These cell findings do not demonstrate clinical vascular outcomes.
01 / Vial strength 20 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 20 mg Vesugen (Lys-Glu-Asp) |
|---|---|
| Final volume | 3 mL |
| Concentration | 6.67 mg/mL |
| One U-100 unit | 66.67 mcg in 0.01 mL |
Standard / Gradual Approach (3 mL = ~6.67 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Week 1 | 500 mcg (0.5 mg) | 7.5 units (0.075 mL) |
| Week 2 | 1000 mcg (1.0 mg) | 15 units (0.15 mL) |
| Week 3 | 1500 mcg (1.5 mg) | 22.5 units (0.225 mL) |
| Weeks 4–8+ | 1500–2000 mcg (1.5–2.0 mg) | 22.5–30 units (0.225–0.30 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.